Work

The Benefits of Glucagon-Like Peptide 1 Agonists in Adult Women with Polycystic Ovary Syndrome

Year: 2026
Type: article
Study design: Systematic Review
Abstract: Background: PCOS is the most common endocrinopathy in women of reproductive age, affecting 5-6 million women in the United States. Symptoms include hirsutism, acne, hormone imbalances, menstrual irregularity, obesity, infertility, hypertension, and hyperlipidemia. GLP-1s are being studied for their benefits in women with PCOS. Purpose: To review the current evidence on the efficacy of GLP-1 receptor agonists in improving symptoms and complications of PCOS. Methods: This scoping literature review used three databases, including CINAHL Ultimate, PubMed, and ClinicalKey. Inclusion criteria were women 18 and older diagnosed with PCOS and studies that evaluated any type of GLP-1 and their effect on PCOS. The metrics being evaluated include anthropometric measures, blood pressure, lipid profiles, sex hormones, metabolic parameters, body composition, menstrual frequency, and pregnancy rate. Results: A total of 15 articles were found. Nine of the studies were meta-analyses, four were randomized study trials, one was a placebo-controlled trial, and one was a retrospective cohort study. GLP-1s reduce BMI, body weight, waist-to-hip ratio, waist circumference, blood pressure, total testosterone, free androgen index, blood glucose levels, fasting insulin, HOMA-IR, and oral glucose tolerance tests. They increase sex hormone binding globulin, menstrual frequency, and pregnancy rates. GLP-1s improve body composition and decrease fat mass on the tongue. The results of improving lipid profiles are mixed. Implications for Practice: For patients with PCOS, GLP-1s should be discussed as a treatment option due to their significant benefits in managing symptoms and reducing health comorbidities. Patients should be educated on the contraindications, possible side effects, and the importance of a healthy diet, strength training, and frequent follow-up while on the medication.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7161923454
FWCI:
Cites: 15
Cited by:
Related to: 10